[Neuronal circuits involved in the physiopathology of parkinsonian syndromes].
D000470:Alkaloids; D000818:Animals; D001921:Brain / Q000503:physiopathology; D002531:Cerebellum / Q000503:physiopathology; D002540:Cerebral Cortex / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D006892:Hydroxydopamines / Q000502:physiology; D007211:Indoles; D008959:Models, Neurological; D008996:Monoamine Oxidase Inhibitors / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009847:Olivary Nucleus / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D011187:Posture; D011725:Pyridines; D012012:Red Nucleus / Q000503:physiopathology; D013378:Substantia Nigra / Q000503:physiopathology
D000470:Alkaloids; D006892:Hydroxydopamines; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines; D004295:Dihydroxyphenylalanine
Les circuits neuronaux impliqués dans la physiopathologie des syndromes parkinsoniens.